A groundbreaking study conducted by researchers at Columbia University Mailman School of Public Health has unveiled a novel biomarker that…
Trending
- PepsiCo launching prebiotic versions of its namesake soda
- Novartis’ Zolgensma sales fall again as gene therapy market woes persist
- Are 5 Million Nondisabled Medicaid Recipients Watching TV All Day? That’s Unsupported
- Study finds key role for non-neural brain cells in processing vision
- Respiratory related ER visits decreased 20% after coal-processing plant closure, study finds
- AstraZeneca says it will invest $50 billion in the U.S. by 2030
- Burger King Is Bringing an International Favorite to U.S. Menus for a Limited Time
- Sarepta will stop shipping Elevidys, Duchenne gene therapy